Navigation Links
IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
Date:3/20/2008

IRVINE, Calif., March 20 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (the Company) (Nasdaq: IDMI) announced today that it has initiated enrollment in a clinical protocol finalized with the U.S. Food and Drug Administration (FDA), which provides mifamurtide (L-MTP-PE) to eligible, high-risk osteosarcoma patients through a compassionate access study.

"This formalized study is in response to the increasing number of requests for compassionate access to L-MTP-PE," said Timothy P. Walbert, president and chief executive officer, IDM Pharma. "As we continue to navigate the U.S. and European regulatory processes, we hope this study provides a temporary solution and much needed treatment option for patients with this devastating orphan disease."

Data from 13 patients treated through compassionate access were presented at the 39th Congress of International Society of Pediatric Oncology (SIOP) last year and showed that L-MTP-PE in combination with other therapies is safe, well-tolerated and exhibited signs of disease control. Updated data on the increasing number of patients treated through compassionate access will be presented at the upcoming 21st Annual Meeting of The American Society of Pediatric Hematology/Oncology (ASPHO).

"This compassionate access study is designed to meet an unmet treatment need by providing L-MTP-PE access to high-risk osteosarcoma patients for whom current therapy is not effective or tolerated," said Peter Anderson, M.D., Ph.D., principal investigator and professor of pediatrics, The University of Texas M. D. Anderson Cancer Center in Houston. "Our experience in treating patients with L-MTP-PE in Phase 1, Phase 2, and Phase 3 studies and through compassionate access has been positive to date with good
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
2. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
3. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
4. Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
5. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
6. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
7. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
8. AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin
9. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
10. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... -- The fairness of the proposed acquisition of Thoratec Corporation ... Jude") is the subject of an investigation by WeissLaw ...  The investigation is focusing on possible breaches of fiduciary ... of Directors of THOR for agreeing to sell the ... announced it had reached a definitive agreement for St. ...
(Date:7/27/2015)... , July 20, 2015 ... has announced the addition of the "Cardiometabolic ... Afrezza,s discounted pricing is in line ... is critical to the product,s commercial appeal. However, ... prevent Afrezza from gaining a sizeable share of ...
(Date:7/27/2015)...  Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is ... the securities of AMAG Pharmaceuticals Inc. ("AMAG" or ... advised to contact Peretz Bronstein or ... at info@bgandg.com or 212-697-6484. ... its officers and/or directors have violated Sections 10(b) ...
Breaking Medicine Technology:WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals Inc. 2
... PRINCETON, N.J. , June 21 Celator Pharmaceuticals today ... (Nasdaq: CEPH). The research agreement provides for the utilization of Celator,s ... at Cephalon. , , ... "We are pleased that work with this research program has ...
... June 21 U.S. District Court Judge Sidney A. Fitzwater ... class action lawsuit that left hundreds of premature babies with life threatening medical ... Canada will receive compensation under the settlement. , ... "It took years of litigation and research to pry relevant information ...
Cached Medicine Technology:Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc. 2Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc. 3Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured 2
(Date:7/27/2015)... ... July 27, 2015 , ... According to an article published by the ... has increased in Tennessee stemming from intravenous drug use. Intravenous drug use causes more ... for contracting communicable diseases including Hepatitis B and C and HIV. Drug treatment facilities ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... , providing a new way to understand and share your geospatial experience. These ... creatively designed maps to solve distinct business problems. , “Our world is more ...
(Date:7/27/2015)... ... July 27, 2015 , ... Dentist in Los Angeles , Dr. Poneh Ghasri, is ... of new beginnings for many people. Teeth whitening can help brighten up a person’s look, ... whitening is the safest and most effective way to get a whiter smile. Dr. Ghasri, ...
(Date:7/27/2015)... ... 2015 , ... Sher Fertility Institute, a national network of fertility ... physician to their clinical team in Las Vegas. , Dr. Mark Severino ... successful Reproductive Endocrinology teams in the region. , Combined Drs. Sher and Severino have ...
(Date:7/27/2015)... ... July 27, 2015 , ... The Advocator Group, LLC, a ... Jon Cogswell as the vice president of client services. Mr. Cogswell has over ... significant role in the growth and transformation of several businesses, including Bob’s Discount ...
Breaking Medicine News(10 mins):Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Is Now Offering a Teeth Whitening Special Just in Time for Summer 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 2Health News:Dr. Mark Severino Joins Dr. Geoffrey Sher at Sher Fertility Las Vegas- Sher Fertility is National Network of Fertility Clinics Known for Exceptional Patient Care 3Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 2Health News:The Advocator Group, LLC Announces Jonathan Cogswell as Vice President of Client Services 3
... come up with a novel idea to boost up the sales of ... has announced a handsome reward of Rs. 100,000 for those who prove ... case has been registered in the state. And despite this, the bird ... Rs.100,000 if anyone proves bird flu case in the state," Rajesh Kumar ...
... the steel town were affected by a mysterious viral fever. ... a slum// cluster in Panposh on the outskirts of Rourkela, famous ... to other parts of the town. ,The high fever ... senior district health official. ,Most of the patients have ...
... days and devouring every bit of the Flu news, ... Own Country// , as recent as yesterday, has demonstrated a ... Flu or no flu. The Kerala Chicken Merchants’ Association threw ... hotel in Malappuram, Kerala. The party was open for all, ...
... Health officials have now urged cat owners to keep pets indoors. ... Ruegen. Initially it is in this region that more than 100 ... head of Germany's Friedrich Loeffler Institute said that the cat could ... disease was also detected among the wild cats in Asia. But ...
... After the cooling down of the bird flu scare, the ... diet of the non-veggies and has decided to bring back ... withdrawn the order prohibiting the serving of chickens and eggs ... catering units," the Railway ministry said in a statement. "It ...
... goods including small cars, anti-AIDS drugs, anti-cancer drugs would ... is one of the highlights of the annual budget ... ,The beneficiaries of this reduction will be the 800, ... the Tata Indica. The prices of 10 anti-AIDS drugs ...
Cached Medicine News:Health News:Bird Flu attacks the feline community 2
The Nervous System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the nervous system....
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
Pocket Medicine's Cardiology Bundle includes the following 4 applications: Treatment Strategies in Cardiovascular Medicine, Treatment Strategies in Interventional Cardiology, Treatment Strategies in ...
Medicine Products: